Skip to content

Clinical trials

Recruiting Kidney Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Neoplasms Status: Recruiting Country / region: China Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20191
20212
20221
20231
20248
202511
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting31

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jinling Hospital, China3
Peking University First Hospital3
RenJi Hospital3
Fudan University2
Shao Pengfei2
Beijing Biotech1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Chinese University of Hong Kong1
Degron Therapeutics Co.1
Essen Biotech1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Neoplasms31
Carcinoma, Renal Cell17
Neoplasms5
Carcinoma4
Lung Neoplasms4
Breast Neoplasms3
Colorectal Neoplasms3
Esophageal Neoplasms3
Melanoma3
Neoplasm Metastasis3

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.